9.82
price up icon3.92%   0.37
after-market Handel nachbörslich: 9.70 -0.12 -1.22%
loading
Schlusskurs vom Vortag:
$9.45
Offen:
$9.53
24-Stunden-Volumen:
4.82M
Relative Volume:
0.88
Marktkapitalisierung:
$2.55B
Einnahmen:
$6.29B
Nettoeinkommen (Verlust:
$750.00M
KGV:
3.4097
EPS:
2.88
Netto-Cashflow:
$586.00M
1W Leistung:
+2.72%
1M Leistung:
+0.72%
6M Leistung:
-38.12%
1J Leistung:
-54.41%
1-Tages-Spanne:
Value
$9.505
$9.84
1-Wochen-Bereich:
Value
$9.40
$9.84
52-Wochen-Spanne:
Value
$8.01
$23.10

Organon Co Stock (OGN) Company Profile

Name
Firmenname
Organon Co
Name
Telefon
551-430-6000
Name
Adresse
30 HUDSON STREET, JERSEY CITY
Name
Mitarbeiter
10,000
Name
Twitter
Name
Nächster Verdiensttermin
2024-10-31
Name
Neueste SEC-Einreichungen
Name
OGN's Discussions on Twitter

Vergleichen Sie OGN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - General icon
OGN
Organon Co
9.82 2.49B 6.29B 750.00M 586.00M 2.88
Drug Manufacturers - General icon
LLY
Lilly Eli Co
776.44 692.83B 49.00B 11.11B -1.27B 12.29
Drug Manufacturers - General icon
JNJ
Johnson Johnson
167.93 373.35B 90.63B 22.66B 18.57B 9.35
Drug Manufacturers - General icon
ABBV
Abbvie Inc
187.11 329.24B 57.37B 4.20B 15.39B 2.35
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
116.83 231.66B 55.19B 13.65B 16.81B 6.86
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
66.78 298.68B 43.59B 15.04B 10.74B 3.3766

Organon Co Stock (OGN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-02 Herabstufung Evercore ISI Outperform → In-line
2024-09-06 Herabstufung JP Morgan Neutral → Underweight
2023-11-03 Herabstufung Goldman Buy → Neutral
2023-09-21 Eingeleitet Barclays Overweight
2023-03-16 Eingeleitet Raymond James Outperform
2022-10-14 Herabstufung BofA Securities Neutral → Underperform
2022-09-06 Hochstufung Piper Sandler Neutral → Overweight
2022-08-05 Herabstufung BofA Securities Buy → Neutral
2022-04-27 Eingeleitet Goldman Buy
2022-04-06 Fortgesetzt Morgan Stanley Equal-Weight
2021-10-07 Eingeleitet Piper Sandler Neutral
2021-09-01 Eingeleitet BofA Securities Buy
2021-07-22 Eingeleitet Citigroup Buy
2021-06-15 Eingeleitet JP Morgan Neutral
2021-06-11 Eingeleitet Morgan Stanley Equal-Weight
2021-06-10 Eingeleitet Evercore ISI Outperform
Alle ansehen

Organon Co Aktie (OGN) Neueste Nachrichten

pulisher
10:00 AM

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Organon & Co. of Class Action Lawsuit and Upcoming DeadlinesOGN - PR Newswire

10:00 AM
pulisher
09:47 AM

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon - Business Wire

09:47 AM
pulisher
08:10 AM

ORGANON FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire

08:10 AM
pulisher
07:31 AM

Organon To Report Second Quarter 2025 Results and Host Conference Call on August 5, 2025 - Business Wire

07:31 AM
pulisher
Jul 21, 2025

The Gross Law Firm Notifies Organon & Co. Investors of a Class Action Lawsuit and Upcoming Deadline – OGN - GlobeNewswire

Jul 21, 2025
pulisher
Jul 21, 2025

July 22, 2025 Deadline Approaching: Join Class Action Against Organon & Co. (OGN)Contact Levi & Korsinsky - ACCESS Newswire

Jul 21, 2025
pulisher
Jul 21, 2025

Organon & Co. (OGN) Restructures, Expands in Women’s Health and Biosimilars - Yahoo Finance

Jul 21, 2025
pulisher
Jul 21, 2025

OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Jul 21, 2025
pulisher
Jul 21, 2025

OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.

Jul 21, 2025
pulisher
Jul 21, 2025

UPDATEDaré Bioscience to Host August 6 Webinar: The DARE to PLAY™ Difference - GlobeNewswire Inc.

Jul 21, 2025
pulisher
Jul 21, 2025

Deadline Soon: Organon & Co. (OGN) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - Business Wire

Jul 21, 2025
pulisher
Jul 21, 2025

Organon & Co. (OGN) LawsuitInvestors Urged to Contact Levi & Korsinsky Before July 22, 2025 - The Globe and Mail

Jul 21, 2025
pulisher
Jul 21, 2025

OGN Investors Have Opportunity to Lead Organon & Co. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire

Jul 21, 2025
pulisher
Jul 21, 2025

The Gross Law Firm Notifies Shareholders of Organon & Co.(OGN) of a Class Action Lawsuit and an Upcoming Deadline - PR Newswire

Jul 21, 2025
pulisher
Jul 21, 2025

ORGANON & CO. (NYSE: OGN) SHAREHOLDER ALERT Bernstein - GlobeNewswire

Jul 21, 2025
pulisher
Jul 21, 2025

INVESTOR DEADLINE TOMORROW: Robbins Geller Rudman & Dowd - GlobeNewswire

Jul 21, 2025
pulisher
Jul 21, 2025

Xponance Inc. Has $206,000 Stock Holdings in Organon & Co. (NYSE:OGN) - Defense World

Jul 21, 2025
pulisher
Jul 20, 2025

Lost Money on Organon & Co. (OGN)? Urged to Join Class Action Before July 22, 2025Contact Levi & Korsinsky - Stockhouse

Jul 20, 2025
pulisher
Jul 20, 2025

Lost Money on Organon & Co. (OGN)? Contact Levi & Korsinsky to Join Class Action Before July 22, 2025 - ACCESS Newswire

Jul 20, 2025
pulisher
Jul 20, 2025

OGN SECURITIES NEWS: Did Organon & Co. (NYSE:OGN) Commit - GlobeNewswire

Jul 20, 2025
pulisher
Jul 20, 2025

Organon & Co. (OGN): Navigating Legal Deadlines and Market Volatility in a Securities Class Action - AInvest

Jul 20, 2025
pulisher
Jul 20, 2025

Securities Lawsuit Alert: Organon & Co. (OGN)Contact Levi & Korsinsky Before July 22, 2025 - ACCESS Newswire

Jul 20, 2025
pulisher
Jul 20, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon - GlobeNewswire

Jul 20, 2025
pulisher
Jul 19, 2025

Class Action Filed Against Organon & Co. (OGN) Over Securities ViolationsContact Levi & Korsinsky Today - Stockhouse

Jul 19, 2025
pulisher
Jul 19, 2025

OGN DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, - GlobeNewswire

Jul 19, 2025
pulisher
Jul 19, 2025

ORGANON DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds - GlobeNewswire

Jul 19, 2025
pulisher
Jul 19, 2025

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon - StreetInsider

Jul 19, 2025
pulisher
Jul 18, 2025

TUESDAY INVESTOR DEADLINE: Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Barchart.com

Jul 18, 2025
pulisher
Jul 18, 2025

ORGANON 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Organon & Co.OGN - FinancialContent

Jul 18, 2025
pulisher
Jul 18, 2025

Organon (OGN) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance

Jul 18, 2025
pulisher
Jul 18, 2025

Organon & Co. Investors: Please contact the Portnoy Law - GlobeNewswire

Jul 18, 2025
pulisher
Jul 18, 2025

Deadline Alert: Organon & Co. (OGN) Investors Who Lost - GlobeNewswire

Jul 18, 2025
pulisher
Jul 18, 2025

The Gross Law Firm Reminds Organon & Co. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 22, 2025OGN - Barchart.com

Jul 18, 2025
pulisher
Jul 18, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Organon & Co.of Class Action Lawsuit and Upcoming DeadlinesOGN - FinancialContent

Jul 18, 2025
pulisher
Jul 18, 2025

OGN SECURITIES FRAUD: Organon & Co. (NYSE:OGN) 27% Stock - GlobeNewswire

Jul 18, 2025
pulisher
Jul 18, 2025

OGN IMPORTANT DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Organon & Co. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 22 Deadline in Securities Class ActionOGN - ACCESS Newswire

Jul 18, 2025
pulisher
Jul 17, 2025

Unpacking Q1 Earnings: Organon (NYSE:OGN) In The Context Of Other Branded Pharmaceuticals Stocks - Yahoo

Jul 17, 2025
pulisher
Jul 17, 2025

2025-07-17 | Class Action Lawsuit Filed Against Organon & Co. (OGN)Recover LossesContact Levi & Korsinsky Before July 22, 2025 | NYSE:OGN | Press Release - Stockhouse

Jul 17, 2025
pulisher
Jul 17, 2025

Shareholders that lost money on Organon & Co.(OGN) Urged to - GlobeNewswire

Jul 17, 2025
pulisher
Jul 17, 2025

Organon & Co. (NYSE: OGN) Investor Alert: Deadline in Lawsuit on July 22, 2025 - openPR.com

Jul 17, 2025
pulisher
Jul 17, 2025

OGN Deadline: OGN Investors with Losses in Excess of $100K Have Opportunity to Lead Organon & Co. Securities Fraud Lawsuit - MarketScreener

Jul 17, 2025
pulisher
Jul 17, 2025

Levi & Korsinsky Notifies Organon & Co. (OGN) Shareholders of Class Action Lawsuit and July 22, 2025 Deadline - ACCESS Newswire

Jul 17, 2025
pulisher
Jul 16, 2025

Levi & Korsinsky Urges Organon & Co. (OGN) Shareholders to Act Before Lead Plaintiff Deadline July 22, 2025 - Stockhouse

Jul 16, 2025
pulisher
Jul 16, 2025

ORGANON SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS - GlobeNewswire

Jul 16, 2025
pulisher
Jul 16, 2025

OGN DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages - GlobeNewswire

Jul 16, 2025
pulisher
Jul 16, 2025

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon - GlobeNewswire

Jul 16, 2025
pulisher
Jul 16, 2025

INVESTOR DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd - GlobeNewswire

Jul 16, 2025
pulisher
Jul 16, 2025

Organon & Co. Sued for Securities Law Violations – - GlobeNewswire

Jul 16, 2025
pulisher
Jul 16, 2025

Stratos Wealth Partners LTD. Has $326,000 Stock Holdings in Organon & Co. (NYSE:OGN) - Defense World

Jul 16, 2025
pulisher
Jul 15, 2025

Contact Levi & Korsinsky by July 22, 2025 to Join Class Action Against Organon & Co. (OGN) - Stockhouse

Jul 15, 2025
pulisher
Jul 15, 2025

ORGANON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Organon & Co. - GlobeNewswire Inc.

Jul 15, 2025

Finanzdaten der Organon Co-Aktie (OGN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
drug_manufacturers_general SNY
$48.75
price up icon 1.71%
$110.17
price up icon 1.75%
drug_manufacturers_general PFE
$25.14
price up icon 3.63%
$305.69
price up icon 3.32%
drug_manufacturers_general MRK
$81.61
price up icon 2.90%
drug_manufacturers_general NVO
$66.78
price up icon 2.87%
Kapitalisierung:     |  Volumen (24h):